Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment

Post time 6 day(s) ago

journal：New England Journal of Medicine

Authors：Sean Wharton; Louis J. Aronne; Adam Stefanski; Nasreen F. Alfaris; Andreea Ciudin; Koutaro Yokote; Bruno Halpern; Alpana P. Shukla; Chunmei Zhou; Lisa Macpherson; Sheryl E. Allen; Nadia N. Ahmad; Suzanne R. Klise

Published date：2025-11-6

DOI：10.1056/nejmoa2511774

PDF link：http://www.nejm.org/doi/pdf/10.1056/NEJMoa2511774

Article link：https://doi.org/10.1056/nejmoa2511774

Article Source：Massachusetts Medical Society。

Remark：

Post time 6 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[NEJM] Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[NEJM] Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[NEJM] Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment